The effect of intraperitoneally administered GABA on brain monoamine metabolism

  • Bratati Biswas
  • Arvid Carlsson


GABA was injected intraperitoneally to rats in single doses of 2.5 to 1500 mg/kg. Thirty minutes after injection a dose-dependent increase in dopamine (DA) and a decrease in noradrenaline (NA) content were observed in the brain. However, in the lowest dose range these levels showed small but significant changes in the opposite direction. The accumulation of dopa after inhibition of the aromatic L-aminoacid decarboxylase was enhanced by i.p. GABA both in DA- and in NA-predominated brain regions, the dose-response relations being complex. Increased levels of serotonin (5-HT), 5-hydroxyindole-acetic acid (5-HIAA) and tryptophan as well as enhanced accumulation of 5-hydroxytryptophan, induced by decarboxylase inhibition were also observed.

The general pattern of effects was similar to that previously observed after intracerebroventricular injection of GABA, although the intraperitoneal doses required were higher. It is suggested that a certain penetration of GABA from the blood into the brain can occur, leading to changes in the physiological activity of monoaminergic neurons.

Key words

GABA Aminooxyacetic acid Dopamine Noradrenaline Serotonin 


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. Andén, N.-E., Stock, G.: Inhibitory effect of gammahydroxybutyric acid and gammaaminobutyric acid on the dopamine cells in the substantia nigra. Naunyn-Schmiedeberg's Arch. Pharmacol. 279, 89–92 (1973)Google Scholar
  2. Atack, C. V.: The determination of dopamine by a modification of the dihydroxyindole fluorimetric assay. Br. J. Pharmacol. 48, 699–714 (1973)Google Scholar
  3. Atack, C., Lindqvist, M.: Conjoint native and orthophthaldialdehyde condensate assay for the fluorimetric determination of 5-hydroxyindole in brain. Naunyn-Schmiedeberg's Arch. Pharmacol. 279, 267–284 (1973)Google Scholar
  4. Atack, C. V., Magnusson, T.: Individual elution of noradrenaline (together with adrenaline), dopamine, 5-hydroxytryptamine and histamine from a single strong cation exchange column, by means of mineral acidorganic solvent mixtures. J. Pharm. Pharmacol. 22, 625–627 (1970)Google Scholar
  5. Bédard, P., Carlsson, A., Lindqvist, M.: Effect of a transverse cerebral hemisection on 5-hydroxytryptamine metabolism in the rat brain. Naunyn-Schmiedeberg's Arch. Pharmacol. 272, 1–15 (1972)Google Scholar
  6. Bertler, Å., Carlsson, A., Rosengren, E.: A method for the fluorimetric determination of adrenaline and noradrenaline in tissues. Acta Physiol. Scand. 44, 273–292 (1958)Google Scholar
  7. Biswas, B., Carlsson, A.: The effect of intracerebroventricularly administered GABA on brain monoamine metabolism. Naunyn-Schmiedeberg's Arch. Pharmacol. 299, 41–46 (1977a)Google Scholar
  8. Biswas, B., Carlsson, A.: Effect of intraperitoneally administered GABA on the locomotor activity of mice. Psychopharmacology, in press (1977b)Google Scholar
  9. Carlsson, A.: Dopaminergic auto-receptors. In: Chemical Tools in Catecholamine Research II. Almgren, O., Carlsson, A., Engel, J. (eds.), pp. 219–225. Amsterdam: North Holland Publishing Company 1975Google Scholar
  10. Carlsson, A., Lindqvist, M.: Effect of ethanol on the hydroxylation of tyrosine and tryptophan in rat brain in vivo. J. Pharm. Pharmacol. 25, 437–440 (1973)Google Scholar
  11. Carlsson, A., Davis, J. N., Kehr, W., Lindqvist, M., Atack, C. V.: Simultaneous measurement of tyrosine and tryptophan hydroxylase activities in brain in vivo using an inhibitor of the aromatic amino acid decarboxylase. Naunyn-Schmiedeberg's Arch. Pharmacol. 275, 153–168 (1972)Google Scholar
  12. Fuxe, K., Agnati, L. F., Hökfelt, T., Jonsson, G., Lidbrink, P., Ljungdahl, Å.: The effect of dopamine receptor stimulating and blocking agents on the activity of suppressive dopamine receptors and on the amine turnover in various dopamine nerve terminal systems in the rat brain. J. Pharmacol. 6, 117–129 (1975)Google Scholar
  13. Gessa, G. L., Vargiu, L., Crabai, F., Boero, G. C., Cagoni, F., Camba, R.: Selective increase of brain dopamine induced by gamma-hydroxybutyrate. Life Sci 5, 1921–1930 (1966)Google Scholar
  14. Hawkins, J. E., Sarett, L. H.: On the efficacy of aspargine, glutamine, γ-aminobutyric acid and 2-pyrrolidinone in preventing chemically induced seizures in mice. Clin. Chim. Acta 2, 48 (1957)Google Scholar
  15. Kehr, W., Carlsson, A., Lindqvist, M.: A method for the determination of 3,4-dihydroxyphenylalanine (DOPA) in brain. Naunyn-Schmiedeberg's Arch. Pharmacol. 274, 273–280 (1972)Google Scholar
  16. Kehr, W., Lindqvist, M., Carlsson, A.: Distribution of dopamine in the rat cerebral cortex. J. Neural Transm. 38, 173–180 (1976)Google Scholar
  17. Kuriyama, K., Sze, P. Y.: Blood brain barrier to H3-γ-aminobutyric acid in normal and aminooxyacetic acid treated animals. Neuropharmacology 10, 103–108 (1971)Google Scholar
  18. Tower, D. B.: The administration of gammaaminobutyric acid to man: systemic effects and anticonvulsant action. In: Inhibition in the Nervous System and Gammaaminobutyric Acid (Roberts, E., Baxter, C. F., Harreveld, A. V., Wiersmar, C. A. G., Adey, W. R., Killam, K. F. (eds.), pp. 562–577. New York: Pergamon Press 1960Google Scholar
  19. Waalkes, T. P., Udenfriend, S.: A fluorimetric method for the estimation of tyrosine in plasma and tissues. J. Lab. Clin. Med. 50, 733–736 (1957)Google Scholar
  20. Wachtel, H., Andén, N.-E.: The motor activity of rats following intracerebral injections of drugs influencing GABA mechanisms. To be published (1977)Google Scholar
  21. Yessaian, N. H., Armenian, A. R., Buniatian, H. Ch.: Effect of γ-aminobutyric acid on brain serotonin and catecholamines. J. Neurochem. 16, 1425–1433 (1969)Google Scholar

Copyright information

© Springer-Verlag 1977

Authors and Affiliations

  • Bratati Biswas
    • 1
  • Arvid Carlsson
    • 1
  1. 1.Department of PharmacologyUniversity of GöteborgGöteborgSweden

Personalised recommendations